T48.4X2 类别:需要更具体的编码 Poisoning by expectorants, intentional self-harm
ICD-10-CM T48.4X2 identifies “Poisoning by expectorants, intentional self-harm” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 19: Injury, poisoning and certain other consequences of external causes
编码说明
无额外说明。
上级编码说明
章节 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T48 · Poisoning by, adverse effect of and underdosing of agents primarily acting on smooth and skeletal muscles and the respiratory system
Seventh character1
The appropriate 7th character is to be added to each code from category T48
A — initial encounter
D — subsequent encounter
S — sequela
更具体的编码
官方索引引用
官方索引引用 (50)
Acetylcysteine (1)
- Acetylcysteine药物和化学物质
Ambroxol (1)
- Ambroxol药物和化学物质
Ammonium (1)
Bromhexine (1)
- Bromhexine药物和化学物质
Calcium (1)
- Calcium › iodide药物和化学物质
Carbocisteine (1)
- Carbocisteine药物和化学物质
Cough mixture(syrup) (2)
- Cough mixture(syrup)药物和化学物质
- Cough mixture(syrup) › expectorants药物和化学物质
Creosote(coal tar) (beechwood) (2)
Deglycyrrhizinized extract of licorice (1)
Domiodol (1)
- Domiodol药物和化学物质
Dornase (1)
- Dornase药物和化学物质
Eprazinone (1)
- Eprazinone药物和化学物质
Expectorant NEC (1)
- Expectorant NEC药物和化学物质
Glycerol (1)
- Glycerol › iodinated药物和化学物质
Glyceryl (1)
- Glyceryl › gualacolate药物和化学物质
Glycyrrhiza extract (1)
- Glycyrrhiza extract药物和化学物质
Glycyrrhizic acid (1)
- Glycyrrhizic acid药物和化学物质
Glycyrrhizinate potassium (1)
- Glycyrrhizinate potassium药物和化学物质
Guaiacol derivatives (1)
- Guaiacol derivatives药物和化学物质
Guaifenesin (1)
- Guaifenesin药物和化学物质
Guaimesal (1)
- Guaimesal药物和化学物质
Guaiphenesin (1)
- Guaiphenesin药物和化学物质
Hydriodic acid (1)
- Hydriodic acid药物和化学物质
Iodide NEC (1)
Iodinated (1)
- Iodinated › glycerol药物和化学物质
Ipecacuanha (1)
- Ipecacuanha药物和化学物质
Letosteine (1)
- Letosteine药物和化学物质
Liquorice (1)
- Liquorice药物和化学物质
Mecysteine (1)
- Mecysteine药物和化学物质
Mesna (1)
- Mesna药物和化学物质
Mucolytic drug (1)
- Mucolytic drug药物和化学物质
Mucomyst (1)
- Mucomyst药物和化学物质
Organidin (1)
- Organidin药物和化学物质
Potassium(salts) NEC (1)
Quillaja extract (1)
- Quillaja extract药物和化学物质
Respaire (1)
- Respaire药物和化学物质
Respiratory drug NEC (1)
S-Carboxymethyl-cysteine (1)
- S-Carboxymethyl-cysteine药物和化学物质
Senega syrup (1)
- Senega syrup药物和化学物质
Sobrerol (1)
- Sobrerol药物和化学物质
Sodium (1)
- Sodium › dibunate药物和化学物质
Sputum viscosity-lowering drug (1)
Stepronin (1)
- Stepronin药物和化学物质
Sulfogaiacol (1)
- Sulfogaiacol药物和化学物质
Superinone (1)
- Superinone药物和化学物质
Tenoglicin (1)
- Tenoglicin药物和化学物质
Terpin(cis) hydrate (1)
- Terpin(cis) hydrate药物和化学物质
Tyloxapol (1)
- Tyloxapol药物和化学物质
历史
编码历史
最近记录的变更 · FY2025 · 04-01
生效日期
- 上级说明变更
Poisoning by expectorants, intentional self-harm
类别 — 请选择更具体的编码
CDC/NCHS · FY2025 · 04-01所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 上级说明变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 上级说明变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 上级说明变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
浏览此类别中更具体的编码。 参考核验不能确定临床适用性,也不保证报销。